Disease/Infection News

RSS

Epidemiology study provides clues for designing new strategies to curb HIV-related mortality in China

In China, HIV-related deaths are on the rise, despite years of efforts by the government to control them. In an effort to overcome this, a new study published in Chinese Medical Journal dug deep into HIV-related data of nearly 30 years.

19 Aug 2021

Phase I clinical study evaluates safety and pharmacokinetics of ExeVir's COVID-19 neutralizing antibody

ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that the first subjects have been dosed in a Phase I clinical study of XVR011, its llama-derived antibody for the treatment and prevention of COVID-19.

19 Aug 2021

Lessons learnt from the COVID-19 swab crisis could help better prepare for future challenges

A major crisis that accompanied the rise of the pandemic was the lack of availability of the nasopharyngeal swab-; necessary for testing for COVID-19, which in turn, was necessary to get a grip on the pandemic. An account of how one group addressed that crisis is published this week Journal of Clinical Microbiology, a journal of the American Society for Microbiology.

19 Aug 2021

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.

19 Aug 2021

White-tailed deer are highly susceptible to SARS-CoV-2 infection

The SARS-CoV-2 virus has been shown to infect a wide range of animals naturally and experimentally, and prior studies indicate deer are susceptible to infection. White-tailed deer (Odocoileus virginianus) fawns have been found to be susceptible to SARS-CoV-2.

19 Aug 2021

Study reveals ideal usage duration of medical face masks

In a paper published by the Journal of Hazardous Materials, researchers from Surrey's renowned Global Centre for Clean Air Research (GCARE) explore two key questions: how long a mask should be worn; and when should it be discarded, recycled or washed to optimize its usage time.

19 Aug 2021

SFU research: Cultural considerations are key to fighting future pandemics

Strategies that not only conform to science but also consider the cultural context of countries are key to fighting future pandemics, according to researchers from Simon Fraser University and two U.S. universities.

19 Aug 2021

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However, the researchers suggest that booster shots may help improve immunity and protect against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

18 Aug 2021

CDC declares four new COVID high-risk travel destinations

The coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome (SARS-CoV-2), is far from over. As the cases continue to rise, countries grapple with controlling the viral spread. To date, over 209 million individuals have been infected with SARS-CoV-2, with more than 17 million cases recorded worldwide over the past 28 days.

18 Aug 2021

Vaccine nationalism may increase COVID-19 case numbers and the emergence of novel variants

The allocation of COVID-19 vaccine between countries has thus far tended toward vaccine nationalism, wherein countries stockpile vaccines to prioritize access for their citizenry over equitable vaccine sharing.

18 Aug 2021

ASU study shows how the COVID-19 pandemic impacted people’s sleep

Sleep has become elusive for many as a result of the coronavirus pandemic, according to new research from Arizona State University's Edson College of Nursing and Health Innovation.

18 Aug 2021

Nearly 140,000 deaths prevented by early U.S. COVID-19 vaccine rollout, study finds

With COVID-19 cases again on the rise in the United States and around the world, vaccination campaigns continue to be of vital importance for a successful return to pre-pandemic life.

18 Aug 2021

Genomic surveillance is vital to combat COVID-19

Although the development and increasingly widespread availability of effective and safe vaccines provides the greatest hope for the future recovery from the increasingly devastating COVID-19 pandemic, genomic surveillance is emerging as a vital necessity to achieve effective mitigation and containment.

18 Aug 2021

Early COVID-19 vaccine campaign averted nearly 140,000 deaths in the U.S.

The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study.

18 Aug 2021

SARS-CoV-2 ORF8 and the expression of cytokine in human macrophages

A new study has determined the production of the SARS-CoV-2 SP-dependent ORF8.

18 Aug 2021

Severe COVID-19 characterized by phosphorylation of STAT1

A new study reports an enhanced expression of STAT1 in mild and severely infected COVID-19 patients as compared to controls

18 Aug 2021

Excess mortality from COVID-19 is the highest since 1918

A recent study provides an assessment of the ongoing pandemic by estimating excess deaths in Sweden, Switzerland, and Spain.

18 Aug 2021

Impact of COVID-19 on the wellbeing of young people

In a recent study, researchers offer recommendations for the wellbeing of children and young people during the pandemic to prevent long-term consequences.

18 Aug 2021

CUNY SPH and NYC Health Department receive $3.3 million grant to test new HIV intervention

The National Institute of Mental Health has awarded the CUNY Graduate School of Public Health and Health Policy and the New York City Department of Health and Mental Hygiene a five-year, $3.3 million grant to test a new strategy to help people living with HIV achieve viral suppression.

18 Aug 2021

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.

18 Aug 2021

Disease/Infection News

Epidemiology study provides clues for designing new strategies to curb HIV-related mortality in China

Phase I clinical study evaluates safety and pharmacokinetics of ExeVir's COVID-19 neutralizing antibody

Lessons learnt from the COVID-19 swab crisis could help better prepare for future challenges

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

White-tailed deer are highly susceptible to SARS-CoV-2 infection

Study reveals ideal usage duration of medical face masks

SFU research: Cultural considerations are key to fighting future pandemics

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

CDC declares four new COVID high-risk travel destinations

Vaccine nationalism may increase COVID-19 case numbers and the emergence of novel variants

ASU study shows how the COVID-19 pandemic impacted people’s sleep

Nearly 140,000 deaths prevented by early U.S. COVID-19 vaccine rollout, study finds

Genomic surveillance is vital to combat COVID-19

Early COVID-19 vaccine campaign averted nearly 140,000 deaths in the U.S.

SARS-CoV-2 ORF8 and the expression of cytokine in human macrophages

Severe COVID-19 characterized by phosphorylation of STAT1

Excess mortality from COVID-19 is the highest since 1918

Impact of COVID-19 on the wellbeing of young people

CUNY SPH and NYC Health Department receive $3.3 million grant to test new HIV intervention

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News